About Intima Bioscience
Intima Bioscience is a company based in New York (United States) founded in 2014.. Intima Bioscience offers products and services including Checkpoint Cell Therapy and Tumor Infiltrating Lymphocytes (TIL). Intima Bioscience operates in a competitive market with competitors including eGenesis, Beam Therapeutics, Korro Bio, Scribe Therapeutics and Tessera Therapeutics, among others.
- Headquarter New York, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Intima Bioscience, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Intima Bioscience
Intima Bioscience offers a comprehensive portfolio of products and services, including Checkpoint Cell Therapy and Tumor Infiltrating Lymphocytes (TIL). The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Uses CRISPR to edit T cells for inhibiting immune checkpoints in cancers
Genetically engineered lymphocytes for treating solid tumor cancers
Funding Insights of Intima Bioscience
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Intima Bioscience
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Intima Bioscience
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Intima Bioscience Comparisons
Competitors of Intima Bioscience
Intima Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as eGenesis, Beam Therapeutics, Korro Bio, Scribe Therapeutics and Tessera Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Gene transplantation platform for humanizing pig cells is developed.
|
|
| domain | founded_year | HQ Location |
Developer of gene therapy using CRISPR base editing to treat diseases
|
|
| domain | founded_year | HQ Location |
RNA-editing technologies are provided for precision medicine applications.
|
|
| domain | founded_year | HQ Location |
A CRISPR-based gene-editing platform is developed for therapeutic applications.
|
|
| domain | founded_year | HQ Location |
New genome engineering technology is provided for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for infectious disease and inflammatory indications
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Intima Bioscience
Frequently Asked Questions about Intima Bioscience
When was Intima Bioscience founded?
Intima Bioscience was founded in 2014.
Where is Intima Bioscience located?
Intima Bioscience is headquartered in New York, United States. It is registered at New York, New York, United States.
What does Intima Bioscience do?
Intima Bioscience was founded in 2014 in New York, United States, within the biotechnology sector. A gene and cell therapeutic platform is being developed for gastrointestinal cancer treatment. Clinical trials are underway, with experiments conducted via the Molecular and Cell Therapy (MCT) GMP manufacturing platform. CRISPR technology is employed to engineer neoantigen-specific tumor-infiltrating lymphocytes that inhibit the intracellular immune checkpoint CISH.
Who are the top competitors of Intima Bioscience?
Intima Bioscience's top competitors include eGenesis, Tessera Therapeutics and Korro Bio.
What products or services does Intima Bioscience offer?
Intima Bioscience offers Checkpoint Cell Therapy and Tumor Infiltrating Lymphocytes (TIL).
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.